Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma
Article in Journal of Neuro-Oncology (October 2023)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Article in Journal of Neuro-Oncology (October 2023)
Article in Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (April 2023)
Book chapter (January 2023)